Money Control Place
  • Politics
  • Business
  • Stocks
  • Investing
  • Politics
  • Business
  • Stocks
  • Investing

Money Control Place

Stocks

Markets Flip as Earnings Season Heats Up

by July 22, 2023
July 22, 2023
Markets Flip as Earnings Season Heats Up

Last week, the number of companies reporting earnings expanded, with heavyweight names Tesla (TSLA) and Netflix (NFLX) getting the most attention. Both companies sold off sharply on Thursday despite beating estimates. The selling spread to other Nasdaq stocks after two heavyweight Semiconductor companies signaled continued weakness in the chip market.

Stocks from beaten-down areas of the market were treated quite differently, however, with healthcare giants Johnson & Johnson (JNJ) and Abbott Labs (ABT) spiking higher after beating guidance and raising their full-year outlook. Bank stocks — another area that’s underperformed amid a crisis — were the biggest winners, as they continued to rally on earnings even if they missed views.

The result was a week where the worst performing sectors year-to-date were last week’s top performeres, while winning sectors were at the bottom.

Could it be that investors are paying attention to valuations as earnings reports roll in? Next week will certainly test this possibility, with four mega-cap companies due to report while a host of additional bank and healthcare companies release results. Microsoft (MSFT), Meta Platform (META), Alphabet (GOOGL), and Amazon (AMZN) are also seeing a rebalance in their Nasdaq 100 weighting on Monday, in addition to their reports later in the week.

Daily Chart of Healthcare Sector

Above is a daily chart of the Healthcare sector after last week’s 3.5% rally pushed the group out of a 3-month base on heavy volume. With the sector poised to trade higher, I believe that pharmaceutical giant Novo Nordisk (NVO) deserves a close look after last week’s move back above resistance at its 50-day moving average.

NVO sells two weight loss drugs while also working on additional treatments that are seeing positive results in trial studies. Today, Wall Street firm Morgan Stanley raised their forecast for annual sales of weight loss drugs to $77 billion, as patient demand for the medicines has outstripped supply amid a social media frenzy.

Daily Chart of Novo Nordisk (NVO)

NVO’s downtrend reversal occurred on above-average volume, while the MACD has just entered positive territory. Both positive characteristics join an already-positive RSI, as can be seen on the daily chart above.

Earnings season has always been a critical period for the markets, as not only is investor sentiment revealed based on responses to results, sector rotation such as last week’s move into Healthcare can take place. If you’d like to be alerted to these critical shifts, use this link here to trial my twice weekly MEM Edge Report. We alerted subscribers to January’s move into Semiconductors while highlighting Nvidia as a buy candidate. The stock has gained 158% since then!

Warm Regards,

Mary Ellen McGonagle, MEM Investment Research

0
FacebookTwitterGoogle +Pinterest
previous post
Machete fight leads to arrest of three Guatemalan illegal immigrants in Boston suburb, now in ICE custody
next post
MEM TV: Tech Stock Decline Spooks Market

Related Posts

Three Industrial Stocks With Room to Run!

March 27, 2024

Spot The Warning Signs of Bankruptcy!

March 16, 2024

Unveiling Market Trends: What’s Triggering a Midweek Bearish...

March 28, 2025

DP Trading Room: Avoid These “Magnificent 7” Stocks!

February 13, 2024

Sector Spotlight: Sector Rotation Says Bull Market in...

July 25, 2023

Stock Market Dips Below 200-Day Moving Average: Are...

March 12, 2025

Are We Seeing 2020 All Over Again!?

December 16, 2023

GNG TV: XOP’s Strength vs. the S&P’s Weakness

September 7, 2023

Breadth Overbought Near-Term

July 15, 2023

Could AMZN’s Stock Hit $3 Trillion Valuation? What...

July 3, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Run Your Stock Portfolio Like a Pro Sports Team

    • Leadership Rotation Could Confirm Corrective Phase

    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right Now

    • 1911 Gold Temporarily Suspends Operations at True North Complex due to Bissett Evacuation Order

    • Ontario Backs Down on Key Bill 5 Provisions, Echoes BC’s Mining Debate

    • Appeals Court Grants Trump Temporary Reprieve on Tariffs, “TACO” Taunts Gain Steam

    Categories

    • Business (1,223)
    • Investing (2,503)
    • Politics (3,699)
    • Stocks (1,614)
    • Uncategorized (20)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: MoneyControlPlace.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 moneycontrolplace.com | All Rights Reserved